ANTI-BAGHOLDER
2年前
$CLRD news out valued at $250 million. Merger with $VHAQ
Norcross, Georgia, and San Antonio, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Viveon Health Acquisition Corp. (NYSE American: VHAQ, VHAQW, VHAQR, VHAQU), a special purpose acquisition company led by principals experienced in healthcare and med-tech innovation, is pleased to announce that it has identified and entered into a letter of intent with a business combination target company, Clearday (OTCQX: CLRD).
https://www.otcmarkets.com/stock/VHAQ/news/story?e&id=2461565
NYCJR
4年前
Viveon Health Acquisition is a blank check company formed under the laws of the State of Delaware on August 7, 2020.
We were formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination.
Our efforts to identify a prospective target business will not be limited to any particular industry or geographic region, although we intend to focus our search on target healthcare businesses operating in North America.
Jagi Gill, PhD, our Chief Executive Officer, has more than 20 years of healthcare investment and general management experience. From 2017 to 2020, he served as the Vice-President of Business Development and General Manager of AcuVentures, a business unit within Acumed LLC, which is a market leader in the orthopedic sector with particular strength in the upper extremity fracture repair and trauma market segments.
As the General Manager, Dr. Gill led two business units, Rib Fixation and the Soft Tissue Repair, with responsibilities for product development, sales, marketing and profitability.
Under his leadership, the business units grew 2-3x faster than their market segment. In addition to general management responsibilities, Dr. Gill was involved in sourcing, closing and integrating four acquisitions within the orthopedic sector for Acumed.
These transactions ranged from technology acquisitions serving as tuck-in product integrations to stand alone companies with global revenue.